GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Synektik SNT.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

327.00

-0.24%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in PLN, from our data supplier.

FY2025

Revenue

PLN 681.3m

FY2016FY2025

Net income

PLN 102.2m

FY2016FY2025

Free cash flow

PLN 59.6m

FY2016FY2025

Shareholders' equity

PLN 222.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenuePLN 681.3mPLN 624.1mPLN 446.9mPLN 166.9mPLN 128.6mPLN 125.4mPLN 134.8mPLN 105.3mPLN 62.9mPLN 49.4m
Gross profitPLN 242.6mPLN 189.9mPLN 131.8mPLN 48.5mPLN 30.3mPLN 30.7mPLN 32.6mPLN 23.7mPLN 14.5mPLN 10.5m
Research and developmentPLN 3.3mPLN 23.3mPLN 16.0mPLN 10.2mPLN 6.1mPLN 5.2mPLN 7.1mPLN 13.2m——
Operating incomePLN 157.0mPLN 106.9mPLN 67.9mPLN 7.0mPLN 11.2mPLN 12.0mPLN 12.7mPLN 11.6mPLN 3.6mPLN 2.1m
Net incomePLN 102.2mPLN 84.6mPLN 52.5mPLN 10.3mPLN 8.4mPLN 8.8mPLN 9.1mPLN 10.3mPLN 4.1mPLN 388,091
Diluted earnings per share11.989.926.151.210.981.031.071.210.480.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsPLN 486.6mPLN 375.3mPLN 299.9mPLN 236.5mPLN 159.7mPLN 141.6mPLN 125.1mPLN 108.6mPLN 115.2mPLN 90.8m
Cash and short-term investmentsPLN 84.3mPLN 84.3mPLN 63.5mPLN 10.9mPLN 18.3mPLN 10.9mPLN 8.6mPLN 5.3mPLN 19.5mPLN 8.1m
Total liabilitiesPLN 263.8mPLN 185.2mPLN 165.7mPLN 148.6mPLN 79.1mPLN 65.6mPLN 54.8mPLN 46.6mPLN 53.5mPLN 33.8m
DebtPLN 40.2mPLN 24.5mPLN 18.7mPLN 36.9mPLN 18.2mPLN 20.6mPLN 12.2mPLN 16.2mPLN 3.3mPLN 5.7m
Shareholders' equityPLN 222.8mPLN 190.0mPLN 134.2mPLN 87.8mPLN 80.6mPLN 76.0mPLN 70.3mPLN 62.0mPLN 61.7mPLN 56.9m
Shares outstanding9m9m9m9m9m9m9m9m9m9m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsPLN 77.7mPLN 89.6mPLN 94.5m−PLN 6.2mPLN 21.7mPLN 13.9mPLN 13.5mPLN 5.2mPLN 14.6m−PLN 8.1m
Capital spending−PLN 18.1m−PLN 44.9m−PLN 8.3m−PLN 10.2m−PLN 3.4m−PLN 5.1m−PLN 5.5m−PLN 2.4m−PLN 6.7m−PLN 7.0m
Free cash flowPLN 59.6mPLN 44.7mPLN 86.2m−PLN 16.4mPLN 18.3mPLN 8.8mPLN 8.0mPLN 2.9mPLN 7.9m−PLN 15.0m
Dividends paid−PLN 70.4m−PLN 25.8m−PLN 5.1m−PLN 3.8m−PLN 3.8m−PLN 3.1m−PLN 3.1m−PLN 3.1m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenuePLN 292.3mPLN 213.2mPLN 228.0mPLN 199.2mPLN 154.2mPLN 124.7mPLN 203.1mPLN 141.8m
Gross profitPLN 94.6mPLN 78.2mPLN 77.6mPLN 76.2mPLN 58.2mPLN 45.6mPLN 62.5mPLN 48.8m
Operating incomePLN 68.2mPLN 53.7mPLN 54.0mPLN 49.5mPLN 36.4mPLN 29.6mPLN 41.5mPLN 25.2m
Net incomePLN 55.1mPLN 296.4mPLN 35.0mPLN 30.9mPLN 23.7mPLN 22.0mPLN 33.1mPLN 21.0m
Diluted earnings per share6.4634.754.103.632.782.583.882.46
Cash from operationsPLN 62.0m−PLN 19.0mPLN 96.0mPLN 36.0m−PLN 5.0m−PLN 63.0mPLN 109.0mPLN 23.0m
Capital spending—−PLN 13.0m−PLN 2.0m−PLN 6.0m−PLN 1.0m−PLN 6.0m−PLN 4.0m−PLN 19.0m
Free cash flow—−PLN 32.0mPLN 94.0mPLN 30.0m−PLN 6.0m−PLN 69.0mPLN 105.0mPLN 4.0m
Total assetsPLN 565.8mPLN 488.2mPLN 605.4mPLN 486.6mPLN 399.3mPLN 380.2mPLN 485.0mPLN 375.3m
Cash and short-term investmentsPLN 78.7mPLN 37.2mPLN 166.2mPLN 84.3mPLN 45.4mPLN 55.5mPLN 187.5mPLN 84.3m
DebtPLN 21.7mPLN 39.0mPLN 23.1mPLN 21.7mPLN 11.8mPLN 14.2mPLN 4.9mPLN 5.3m
Shareholders' equityPLN 214.2mPLN 158.7mPLN 258.3mPLN 222.8mPLN 191.2mPLN 167.1mPLN 223.1mPLN 190.0m

Financial ratios

Data as of 27 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin35.6%30.4%29.5%29.1%23.5%24.5%
Operating margin23.3%16.9%15.1%8.2%8.3%9.6%
Net margin15.0%13.6%11.7%6.2%6.5%7.0%
Return on equity45.9%44.5%39.1%11.7%10.4%11.6%
Return on assets21.0%22.6%17.5%4.4%5.3%6.2%
Free cash flow yield3.4%4.7%3.6%0.1%0.9%0.7%
Revenue growth9.2%39.7%167.8%29.7%2.6%-7.0%
Earnings growth20.7%61.4%409.2%22.9%-4.8%-3.6%
Current ratio1.65x1.58x1.43x1.05x1.16x1.34x
Debt to equity0.10x0.03x0.04x0.28x0.13x0.18x
Equity ratio45.8%50.6%44.7%37.1%50.4%53.7%
Interest coverage51.30x73.03x35.51x9.44x22.12x20.16x
R&D as a share of sales0.5%3.7%3.6%6.1%4.8%4.2%
Buybacks as a share of market value0.0%0.0%0.0%0.0%0.0%0.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue59.8%40.3%23.3%
Operating income181.5%67.2%—
Net income114.9%63.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.1%31.9%31.0%29.3%
Operating margin20.2%17.7%16.7%15.0%
Net margin14.3%13.0%12.3%11.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings23.620.014.024.429.426.414.47.435.3347.0
Price to sales3.52.71.61.51.91.91.00.72.32.7

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 28 Jan 2026.

FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year10.7511.280.600.450.450.36

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.